References
- Back D. J., Tija J. F. Inhibition of tolbutamide metabolism by suitably substituted imidazole drugs in vivo: Evidence for a structure-activity relationship. British Journal of Pharmacology 1985; 85: 121–126
- Devonshire H. W., Kong I., Cooper T. P., Idle J. R., Smith R. L. The contribution of genetically determined oxidation status to interindividual variation in phenacetin disposition. British Journal of Clinical Pharmacology 1983; 16: 157–166
- Distlerath L. M., Reilly P. E. B., Martin M. V., Davis G. S., Wilkinson G. R., Guengerich F. P. Purification and characterisation of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1985; 260: 9057–9067
- Duggleby R. G. Regression analysis of nonlinear arrhenius plots: an empirical model and a computer program. Computers in Biology and Medicine 1984; 14: 447–455
- Ellis K. J., Duggleby R. G. What happens when data are fitted to the wrong equation?. Biochemical Journal 1978; 171: 513–517
- Flind A. C. Cimetidine and oral anticoagulants. British Medical Journal 1978; 2: 1367
- Gillam E. M. G., Reilly P. E. B. Phenacetin deethylation by human liver microsomes: Kinetics and propranolol inhibition. Xenobiotica 1987; 18: 95–104
- Ioannoni E., Mason S. R., Reilly P. E. B., Winzor D. J. Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine–Binding and kinetic studies. Archives of Biochemistry and Biophysics 1986; 247: 372–383
- Kirch W., Spahn H., Köhler H., Ohnhaus E. E., Mutschler E. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klinische Wochenschrift 1982; 60: 1401–1407
- Lennard M. S., Crewe H. K., Tucker G. T., Woods H. F. Histamine: an inhibitor of cytochrome P-450-catalysed drug metabolism. Biochemical Pharmacology 1986a; 35: 2459–2460
- Lennard M. S., Crewe H. K., Tucker G. T., Woods H. F. Metoprolol oxidation by rat liver microsomes—Inhibition by debrisoquine and other drugs. Biochemical Pharmacology 1986b; 35: 2757–2761
- Lennard M. S., Silas J. H., Freestone S., Ramsey L. E., Tucker G. T., Woods H. F. Oxidation phenotype—A major determinant of metoprolol metabolism and response. New England Journal of Medicine 1982; 307: 1558–1560
- Lindstrom T. D., Whitaker G. W., Pioch R. P. Inhibition of microsomal biotransformation by a series of nitrogen and oxygen heterocyclic histamine H2-antagonists. Biochemical Pharmacology 1987; 36: 1669–1672
- Powell J. R., Donn M. S. Histamine H-2 antagonists drug interactions in perspective: Mechanistic concepts and clinical implications. American Journal of Medicine 1984; 77: 57–84
- Rendic S., Kajfez F., Ruf H-H. Characterisation of cimetidine, ranitidine and related structures' interaction with cytochrome P-450. Drug Metabolism and Disposition 1983; 11: 137–142
- Rogerson T. D., Wilkinson C. F., Hetnarski K. Steric factors in the inhibitory interaction of imidazoles with microsomal enzymes. Biochemical Pharmacology 1977; 26: 1039–1042
- Silver B. A., Bell W. R. Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Annals of Infernal Medicine 1979; 90: 348–349
- Somogyi A., Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics 1987; 12: 321–366
- Spahn H., Mutschler E., Kirch W., Ohnhaus E. E., Janisch H. D. Influence of ranitidine on plasma metoprolol and atenolol concentrations. British Medical Journal 1983; 286: 1546–1547
- Toon S., Hopkins K. J., Garstang F. M., Rowland M. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. European Journal of Clinical Pharmacology 1987; 32: 165–172
- Wilkinson C. F., Hetnarski K., Yellin T. O. Imidazole derivatives—A new class of microsomal enzyme inhibitors. Biochemical Pharmacology 1972; 21: 3187–3192